VOYA Investment Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38,574
| Closed | -$162K | – | 3076 |
|
|
2023
Q1 | $162K | Hold |
38,574
| – | – | ﹤0.01% | 2599 |
|
|
2022
Q4 | $232K | Hold |
38,574
| – | – | ﹤0.01% | 2495 |
|
|
2022
Q3 | $225K | Buy |
38,574
+3,188
| +9% | +$19.9K | ﹤0.01% | 2532 |
|
|
2022
Q2 | $211K | Buy |
+35,386
| New | +$181K | ﹤0.01% | 2367 |
|
|
2019
Q2 | – | Sell |
-18,717
| Closed | -$18K | – | 2675 |
|
|
2019
Q1 | $18K | Hold |
18,717
| – | – | ﹤0.01% | 2547 |
|
|
2018
Q4 | $14K | Hold |
18,717
| – | – | ﹤0.01% | 2544 |
|
|
2018
Q3 | $40K | Hold |
18,717
| – | – | ﹤0.01% | 2573 |
|
|
2018
Q2 | $93K | Buy |
+18,717
| New | +$81.9K | ﹤0.01% | 2532 |
|
|
2016
Q2 | – | Sell |
-10,126
| Closed | -$54K | – | 2647 |
|
|
2016
Q1 | $54K | Hold |
10,126
| – | – | ﹤0.01% | 2475 |
|
|
2015
Q4 | $125K | Hold |
10,126
| – | – | ﹤0.01% | 2435 |
|
|
2015
Q3 | $148K | Hold |
10,126
| – | – | ﹤0.01% | 2386 |
|
|
2015
Q2 | $197K | Sell |
10,126
-1,370
| -12% | -$26.4K | ﹤0.01% | 2490 |
|
|
2015
Q1 | $208K | Hold |
11,496
| – | – | ﹤0.01% | 2413 |
|
|
2014
Q4 | $271K | Hold |
11,496
| – | – | ﹤0.01% | 2329 |
|
|
2014
Q3 | $278K | Hold |
11,496
| – | – | ﹤0.01% | 2313 |
|
|
2014
Q2 | $323K | Sell |
11,496
-2,746
| -19% | -$82.5K | ﹤0.01% | 2296 |
|
|
2014
Q1 | $484K | Buy |
+14,242
| New | +$487K | ﹤0.01% | 1991 |
|
Other funds holding CTIC
VOYA Investment Management's CTIC Position: Q2 2023 in Review
VOYA Investment Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 38,574 shares — an estimated $162K sold.
VOYA Investment Management first reported a position in CTIC in Q1 2014 and held it in 17 quarters. The position peaked at $484K in Q1 2014. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- VOYA Investment Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- VOYA Investment Management sold 38,574 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $162K.
- VOYA Investment Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2014 and held it in 17 quarters.
- VOYA Investment Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $484K in Q1 2014.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.